Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Cancer trials: making the most of biomarkers

Biomarkers are becoming increasingly important in oncology clinical trials, as they offer a route to more effective (and cost-effective) targeted therapies. Dr David Parker of Precision for Medicine discusses the evolving role of biomarkers in cancer drug development.

Go Top